Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL339199 | 0.87 | SIGMAR1 (0.47) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL4590848 | 0.79 | CYP2D6 (0.47) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL21060575 | 0.78 | SIGMAR1 (0.42) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL4590844 | 0.77 | ALDH1A1 (0.40) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL2181964 | 0.76 | TAAR1 (0.47) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL339627 | 0.72 | SIGMAR1 (0.42) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL28065353 | 0.71 | SIGMAR1 (0.45) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL22245282 | 0.69 | TAAR1 (0.39) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL1765853 | 0.69 | TRPA1 (0.46) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL1972957 | 0.68 | TAAR1 (0.38) | SIGMAR1SLC6A2TAAR1MAOASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070286994-A1 | DURABLE ANTIREFLECTIVE FILM | 3M INNOVATIVE PROPERTIES COMPANY | 2007-12-13 | — | — | US | claimed |
| US-20150175812-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2015-06-25 | — | — | US | disclosed |
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-01-19 | — | — | US | disclosed |
| US-20080240479-A1 | HYDROPHOBIC AND OLEOPHOBIC COATING AND METHOD FOR PREPARING THE SAME | SONIC INNOVATIONS, INC. | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | ARG1, CAPG, CLSPN | SIGMAR1 673/4885SLC6A2 3196/4885TAAR1 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.